Dembinski et al. found that microenvironments of OC recruit MSCs after its intraperitoneally administered to participate in their stroma development, and gene-modified MSC to express IFN-β, achieved to control or eradicate ovarian tumour in tumour xenograft models, resulting in reduction of tumour growth and prolonged survival [39]. The gene discussed is IFNB1; the disease is neoplasm.